SCHEMBL5774581

SCHEMBL5774581

CCOC(=O)c1cnoc1-c1cc(C)cs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
GAA P10253 4/20 0.39
MAPK1 P28482 1/20 0.39
KDM4E B2RXH2 7/20 0.38
HPGD P15428 5/20 0.38
CASP1 P29466 1/20 0.38
TSHR P16473 1/20 0.37
HSD17B10 Q99714 3/20 0.37
RECQL P46063 1/20 0.37
PKM P14618 1/20 0.37
CHEK2 O96017 1/20 0.37
MAPT P10636 3/20 0.37
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
GLA P06280 1/20 0.36
IDO1 P14902 1/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774739 0.77 BAZ2B (0.41) ALDH1A1KMT2AMEN1GAAMAPK1
SCHEMBL5774794 0.76 NPSR1 (0.51) ALDH1A1KMT2AMEN1GAAMAPK1
SCHEMBL22106312 0.76 TSHR (0.44) ALDH1A1KMT2AMEN1GAAMAPK1
SCHEMBL5773388 0.75 TARBP2 (0.48) ALDH1A1KMT2AMEN1GAAMAPK1
SCHEMBL5770551 0.73 SMN1; SMN2 (0.44) ALDH1A1KMT2AMAPK1KDM4EHPGD
SCHEMBL6502372 0.72 TSHR (0.53) ALDH1A1KMT2AMEN1GAAMAPK1
SCHEMBL20028542 0.72 KDM4E (0.41) ALDH1A1KMT2AMEN1GAAMAPK1
SCHEMBL3884597 0.72 TSHR (0.50) ALDH1A1KMT2AMEN1GAAMAPK1
SCHEMBL8825122 0.71 ALDH1A1 (0.42) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL5773242 0.71 CCNC (0.36) KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR ALDH1A1 1045/4885KMT2A 3907/4885MEN1 2811/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 ALDH1A1 682/4885KMT2A 2906/4885MEN1 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.